T Cells

LONDON, July 16, 2026 GSK plc has officially completed its acquisition of Nuvalent, Inc., marking a major strategic expansion...

CAMBRIDGE, Mass., July 16, 2026 Moderna, Inc. has announced the first participant has been dosed in its Phase 1...

CULVER CITY, Calif., June 1, 2026 ImmunityBio announced new clinical and comparative data from its ANKTIVA® (nogapendekin alfa inbakicept-pmln)...